Ad
related to: athx biotech investor news dailydirexion.com has been visited by 100K+ users in the past month
- ETF Line-up
View Direxion's Complete List of
Leveraged and Inverse ETFs.
- Pharma ETF
Direxion Pharma & Medical ETF
Daily Bull 3X Shares - PILL
- Healthcare ETF
Direxion Daily Healthcare ETF
Bull 3X Shares ETF - CURE
- Education
Articles, videos & tools to help
understand Leveraged ETFs and more.
- ETF Line-up
Search results
Results From The WOW.Com Content Network
Athersys (ATHX) gains on encouraging results from its exploratory study on the intravenous administration of MultiStem cell therapy to treat patients suffering from ARDS.
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The Financial News Network (FNN) was an American financial and business news television network launched on November 30, 1981. The network aimed to broadcast programming nationwide, five days a week, for seven hours a day on thirteen stations, in an effort to expand the availability of business news for public dissemination.
Patrick Soon-Shiong (born July 29, 1952) is a South African and American businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer.
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
Jason Matthew Daniel Pontin (born 11 May 1967) is a British-born venture capitalist and journalist. He is a General Partner at the venture capital firm of DCVC in Palo Alto, and is a board member and seed investor in a number of life sciences companies.
Ad
related to: athx biotech investor news dailydirexion.com has been visited by 100K+ users in the past month